Biosimilar Manufacturing solution center

1. U.S. Pharma Tariffs And MFN Become Law After April 2 Update 4/15/2026

   Beginning July 31, 2026, a U.S. pharmaceutical tariff will apply to patented products and their APIs, beginning with large companies. Beroe Inc.'s Mathini Ilancheran breaks down the tariff's impact, explores its risks, and proposes five procurement strategies to addressing them.

2. How To Implement Post-Approval Changes On A Global Level 4/14/2026

   To prepare for inevitable process changes after market authorization, this overview provides critical planning advice for assessing risk and minimizing delays.

3. The Business Case For Continuous Manufacturing In Biologics 4/14/2026

   The question for leadership is not if continuous manufacturing will transform biologics, but when and how quickly to invest.

4. Microbial Integrity Of Sampling Systems After Multiple Actuations 4/6/2026

   Repeated sampling doesn’t have to mean increased contamination risk. See how microbial ingress testing demonstrates sterility integrity after up to 50 sampling actuations.

5. From Principles To Practice: Building Quality Into Generative AI-Assisted Pharma Operations 4/6/2026

   Learn what regulators are already asking about AI, what quality must mean in this new context, and how organizations can begin building the governance infrastructure.

6. New Research: Co-Expression Could Make Plant-Based Systems Viable 4/2/2026

   By co-expressing Protein A with the protein of interest, the work proposes to reduce the abundant cost of chromatography resins with a one-pot purification approach.

7. Quantifying Single-Use Waste Produced During mAb Manufacture 4/2/2026

   Discover the current scale of plastic single-use technology waste and its projected growth, specifically for the biomanufacturing domain. There is an increasing need for sustainable solutions.

8. Mitigating Risks With Smart Inventory Management 3/31/2026

   Unplanned downtime often starts with a missing spare part. Learn how lean, data‑driven inventory strategies can reduce risk, support compliance, and keep bioprocessing operations running smoothly.

9. Remote Equipment Monitoring 3/31/2026

   Real‑time equipment visibility is becoming essential for modern bioprocessing. Learn how remote monitoring helps reduce downtime, support compliance, improve sustainability, and keep operations running.

10. Future-Proof Workflows With Preventive Maintenance 3/31/2026

    Preventive maintenance helps bioprocessing teams reduce downtime, control costs, and stay inspection‑ready. Learn how proactive, data‑driven maintenance strategies can protect equipment performance.